Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 17920183)

1.

Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence.

Tsakiris P, de la Rosette JJ, Michel MC, Oelke M.

Eur Urol. 2008 Jan;53(1):53-9. Epub 2007 Oct 1. Review.

PMID:
17920183
2.

Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.

Mariappan P, Alhasso A, Ballantyne Z, Grant A, N'Dow J.

Eur Urol. 2007 Jan;51(1):67-74. Epub 2006 Sep 15. Review.

PMID:
17014950
3.

Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.

Mariappan P, Ballantyne Z, N'Dow JM, Alhasso AA.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004742. Review.

PMID:
16034945
4.

[Pharmacological treatment for stress urinary incontinence in prostate cancer].

Puyol M, Collado A.

Arch Esp Urol. 2009 Dec;62(10):882-8. Review. Spanish.

PMID:
20068265
5.

[Pharmacotherapy of stress incontinence].

Jost WH, Marsalek P, Michel MC.

Dtsch Med Wochenschr. 2005 Oct 14;130(41):2337-42. Review. German.

PMID:
16231235
6.

[Update on medical treatment of female stress urinary incontinence].

Yazbeck C, Dhainaut C, Batallan A, Thoury A, Madelenat P.

Gynecol Obstet Fertil. 2004 Jun;32(6):556-61. Review. French.

PMID:
15217571
7.

Nonsurgical treatment of stress urinary incontinence (SUI): grading of evidence in systematic reviews.

Latthe PM, Foon R, Khan K.

BJOG. 2008 Mar;115(4):435-44. doi: 10.1111/j.1471-0528.2007.01629.x. Review.

PMID:
18271880
8.

Duloxetine in women awaiting surgery.

Drutz H.

BJOG. 2006 May;113 Suppl 1:17-21. Review.

PMID:
16529565
9.

The use of Duloxetine in the treatment of male stress urinary incontinence.

Fink KG, Huber J, W├╝rnschimmel E, Schmeller NT.

Wien Med Wochenschr. 2008;158(3-4):116-8. doi: 10.1007/s10354-007-0494-7.

PMID:
18330528
10.

Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training.

Brunenberg DE, Joore MA, Veraart CP, Berghmans BC, van der Vaart CH, Severens JL.

Clin Ther. 2006 Apr;28(4):604-18.

PMID:
16750472
11.
12.

Duloxetine: a new approach for treating stress urinary incontinence.

Moore K.

Int J Gynaecol Obstet. 2004 Jul;86 Suppl 1:S53-62. Review.

PMID:
15302567
13.

Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy.

Schlenker B, Gratzke C, Reich O, Schorsch I, Seitz M, Stief CG.

Eur Urol. 2006 Jun;49(6):1075-8. Epub 2006 Feb 6.

PMID:
16481094
14.
15.

Safety and tolerability of duloxetine in women with stress urinary incontinence.

Oelke M, Roovers JP, Michel MC.

BJOG. 2006 May;113 Suppl 1:22-6. Review.

PMID:
16529566
16.

Pharmacotherapy for stress urinary incontinence : present and future options.

Zinner NR, Koke SC, Viktrup L.

Drugs. 2004;64(14):1503-16. Review.

PMID:
15233589
18.

Pharmacologic treatment of stress urinary incontinence: expectations for outcome.

Schuessler B, Baessler K.

Urology. 2003 Oct;62(4 Suppl 1):31-8. Review.

PMID:
14550835
19.

Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.

Zinner NR.

Expert Opin Investig Drugs. 2003 Sep;12(9):1559-66. Review.

PMID:
12943499
20.

[A prospective control study on treatment of stress urinary incontinence with alpha-adrenoceptor agonists and pelvic floor muscle exercises].

Zhu L, Lang JH, Hai N, Li Y, Xiao H.

Zhonghua Fu Chan Ke Za Zhi. 2006 Aug;41(8):537-9. Chinese.

PMID:
17083839
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk